Massachusetts Prevention Alliance

The Marijuana Policy Initiative

Section I.Mobilizing and the Marijuana

Prevention Initiative in Massachusetts

February 2, 2012

What is the Massachusetts Prevention Alliance?

VisionThe Massachusetts Prevention Alliance

envisions a day when the health and well-being of all Massachusetts youth is central in all policies.

February 2, 2012

What is the Massachusetts Prevention Alliance?

MissionThe Massachusetts Prevention Alliance is a statewide organization that provides educational resources and advocates for sound public health and safety policies to protect andpromote the health and well-being of all Massachusetts youth.

February 2, 2012

May: Statewide Conference Call on

Increased Marijuana rates

May: Statewide Conference Call on

Increased Marijuana rates

Nov: Prop 2

Decriminalization passes

Nov: Prop 2

Decriminalization passes

Nov:Alcohol tax is repealed

by MA voters

Nov:Alcohol tax is repealed

by MA voters

Nov 4: We make contact with Dr. Kevin Sabet shortly after he leaves White House

Nov 4: We make contact with Dr. Kevin Sabet shortly after he leaves White House

Nov 29:DFC Action

Group meets in Brockton

Nov 29:DFC Action

Group meets in Brockton

Feb 2:MAPA’s Debut

Fall: New MA DFC

Program Officer

Fall: New MA DFC

Program Officer

Jan: Meeting with Greg Grass at

CADCA Conference plants seed for

mobilization effort

Jan: Meeting with Greg Grass at

CADCA Conference plants seed for

mobilization effort

Nov 3:DFC Coalitions meet w/ Greg

Grass in Brockton

Nov 3:DFC Coalitions meet w/ Greg

Grass in Brockton

Nov 14:Conference Call:

Sue Thau, Michael Sparks

Nov 14:Conference Call:

Sue Thau, Michael Sparks

Dec:MAPA Steering

Committee Organizes &

Discusses resources needed

Dec:MAPA Steering

Committee Organizes &

Discusses resources needed

Nov 8: Connect

with Ohio

Action Alliance(Position

Paper)

Nov 8: Connect

with Ohio

Action Alliance(Position

Paper)

2008 2010 2011 2012

February 2, 2012

I. MA Prevention Alliance. Create a coordinated, collective force to influence policy in the interest of youth health and safety, and raise awareness of the effectiveness of prevention in all facets of reducing youth substance use.

II. Address the immediate medicinal marijuana threat to the Commonwealth. Educate residents on the unintended and unforeseen consequences of MM policy, including youth access, perception of risk, and the bad precedent and health practice of circumventing the FDA process for approval of medicine.

Two simultaneous efforts

February 2, 2012

Structure of the Massachusetts Prevention Alliance

Steering Committee

Marijuana Prevention Initiative

Summit Planning

Committee

Advisory Committee Partners

Organizational Development

Committee

Resource Development

Committee

Communications Committee

Outreach & Membership Committee

February 2, 2012

“ A group is working on advocacy efforts related to marijuana policies in the state and how proposed changes would affect youth prevention goals. I applaud these efforts; because environmental prevention strategies are at the heart of DFC goals, you are encouraged to participate in and support these efforts - where they align with your goals in your action plans and logic models, and where the data you collect shows youth marijuana use is problematic.”

- Greg Grass, DFC Program Officer, SAMHSA, December 15, 2011

February 2, 2012

Funding The Initiative

• Anticipated program and project costs:– Expert consultant/coordinator between now and

November– Event planning– Materials/messaging/web site/communication costs– Filing 501c3 & 501c4

• Coalitions (DFC) asked and allowed to set aside $3K-$5K to cover the costs for this effort.

February 2, 2012

Dr. Kevin Sabet, former Obama, Bush, Clinton Advisor on drugs and consultant and columnist on drug policies (New York Times, Huffington Post, etc.). Dr. Sabet is an expert in evidence-based drug prevention, treatment, and law enforcement both domestically and internationally. His specialty is in drug legalization and “medical” marijuana.

February 2, 2012

Understanding the Difference Between Lobbying v Advocacy

• Not asking anyone to “lobby” but rather advocate for sensible policies that promote DFC objectives.

• Lobbying is having a position on a specific bill/piece of legislation and urging someone to vote one way or another.

• If that situation comes up and we only have fed dollars to work with, we will not expend ANY fed dollars on it but rather volunteer our time, which is permitted.

February 2, 2012

Understanding the Difference

Between Lobbying and Advocacy

• SAMHSA position• CADCA position• ONDCP position

February 2, 2012

What is our Initiative?

We want to protect the health and well-being of all Massachusetts youth by educating stakeholders (parents, law enforcement, legislators, youth workers, voters, etc.) on the threats of legalizing marijuana as a medicine through the legislative process and/or ballot measure.

February 2, 2012

Why do we care about this?

February 2, 2012

Section 2.Health Risks of Marijuana Use

February 2, 2012

Acute Effects of Marijuana – During Intoxication (1)

• Euphoria • Calmness• Appetite stimulation• Altered perception of time• Impairs coordination and balance• Acute psychosis; Panic (anxiety)• Increases heart rate: 20 - 100%

– Some evidence for increased risk of heart attack, may be exacerbated in vulnerable individuals (e.g., baby boomers)

• Impaired Driving– Increased risk of accidents– Increased culpability

1. Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use. Lancet, 374:1383-1391.February 2, 2012

Acute Effects of Marijuana – During Intoxication

• Cognitive Dysfunction (1)– Impaired short-term memory

• Difficulty with complex tasks• Difficulty learning

– Impaired decision-making• Increased risky sexual behavior – HIV

• Increased Risk of Injuries (2)– 30% higher according to one Kaiser study – Increased risk of hospitalized injury from all causes: self-inflicted, motor

vehicle, assaults– Individuals admitted into hospitals with marijuana abuse/dependence as

their primary diagnosis have median lengths of stay that are twice to three times longer than those experienced by patients admitted for alcohol, cocaine or heroin and therefore result in higher average charges

1. NIDA, Research Report Series: Cannabis Abuse, 2010 & Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use. Lancet, 374:1383-1391..

2. Polen, M.R; Sidney, S.; Tekawa, I.S.; Sadler. M.; and Friedman, G.D. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158:596-601, 1993.

Pacula RL, Ringel J, Dobkins C, and K Truong, "The Incremental Health Services Cost Associated with Marijuana Use," Drug and Alcohol Dependence, 92:248-257, 2008. February 2, 2012

Emergency Department Marijuana Mentions

In 2008, there were >370,000 ED visits with Marijuana mentions

Source: SAMHSA, Drug Abuse Warning Network, 2008.February 2, 2012

Long-Term Effects of Marijuana

•Cognitive Impairment (1)– Deficits in learning, memory, attention, executive function– Greater impulsivity, less cognitive flexibility– Reversible with prolonged abstinence

•Negative Impact on Educational Outcomes (2)– Greater drop out rates– General dissatisfaction with life achievement, mental health, social

relationships

1. Solowij, N., et al. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287, 1123-1131. and Schweinsburg AD, Brown, SA, & Tapert, SF (2008). The influence of cannabis use on neurocognitive functioning in adolescents. Current Drug Abuse Reviews, 1:99-111.

2. Macleod, J.; Oakes, R.; Copello, A.; Crome, I.; Egger, M.; Hickman, M.; Oppenkowski, T.; Stokes-Lampard, H.; and Davey Smith, G. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 363(9421):1579-1588, 2004.

February 2, 2012

Long-Term Effects of Marijuana• Brain Effects (1)

– Structural abnormalities have not been consistently identified. – But chronic users show consistent alterations in brain activation of

higher cognitive networks. – Emerging preliminary evidence suggests that heavy cannabis use

during adolescence may affect normal brain development.

• Respiratory system (2)– Increases cough, phlegm production, and wheezing. – Increased bronchitis, worsening of asthma symptoms or cystic fibrosis

symptoms– No increase in emphysema– Conflicting evidence for lung/upper airway cancer

1. Giedd. J. N. (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the NY Academy of Sciences, 1021, 77-85. and Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use. Lancet, 374:1383-1391.

2. Tetrault, J.M., et al. Effects of cannabis smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 167, 221-228 (2007).

Tashkin, DP (2005). Smoked cannabis as a cause of lung injury. Monaldi Archives for Chest Disease, 63(2):93-100. NIDA, Research Report Series: Cannabis Abuse, 2010. Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use. Lancet, 374:1383-1391.

February 2, 2012

Long-Term Effects of Marijuana• Mental illness

– Population studies have found evidence of an association between cannabis use and increased risk of schizophrenia (and/or psychotic symptoms), and to a lesser extent, depression, anxiety, and suicidal behavior/ideation. (1)

1. McGrath, et al. (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry, 67(5):440-447.

Room, R., Fischer, B., Hall, W., Lenton, S. and Reuter, P. (2010). Cannabis Policy: Moving Beyond Stalemate, Oxford, UK: Oxford University Press.

Large, M., Sharma S, Compton M., Slade, T. & O., N. (2011). Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry. 68. Also see Arseneault L, et al. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal. 325, 1212-1213.

February 2, 2012

Long Term Effects of MarijuanaAddiction: About 9% of users may become dependent, 1 in 6

who start use in adolescence, 25-50% of daily users

32

15

9

17

118

5

23

05

101520253035

Perc

ent

Source: Wagner, F.A. & Anthony, J.C. From first drug use to drug dependence; developmental periods of risk for dependence upon cannabis, cocaine, and alcohol. Neuropsychopharmacology 26, 479-488 (2002).

Estimated Prevalence of Dependence Among Users * *

February 2, 2012

Dependence on or Abuse of Specific Illicit Drugs in the Past Year Among Persons 12 or Older, 2008

Source: Substance Abuse and Mental Health Services Administration. (2009). Office of Applied Studies. Treatment Episode Data Set (TEDS): 2009 Discharges from Substance Abuse Treatment Services, DASIS.

February 2, 2012

Increased Marijuana Treatment Admissions 1993 and 2007

Source: Treatment Episode Data Set, US Health and Human Services, 1993 & 2007.February 2, 2012

Treatment Admissions by Drug, 2007

Source: Treatment Episode Data Set, US Health and Human Services, 1993 & 2007.February 2, 2012

Potency: Increased THC Content in Seized Marijuana, 1983-2009

Source: The University of Mississippi Potency Monitoring Project

Year

February 2, 2012

What Does Increased Potency Mean?

• Potential for greater exposure, more adverse health effects, higher rates of addiction

• ER visits involving marijuana have been going up

Dependence rates increased between 1992-2002 in specific subgroups (1)

1. Compton, W., Grant, B., Colliver, J., Glantz, M., Stinson, F. Prevalence of Cannabis Use Disorders in the United States: 1991-1992 and 2001-2002 Journal of the American Medical Association.. 291:2114-2121.

February 2, 2012

2009 Marijuana Use by High School Students (MA and US)

Question MA (%) US (%)

Lifetime marijuana use 42.5 36.8

First marijuana use before age 13 9.0 7.5

Past 30-day use of marijuana 27.1 20.8

Past 30-day marijuana use on school property 5.9 4.6

Source: Centers for Disease Control and Prevention, Youth Online: High School YRBS.

February 2, 2012

Marijuana Use at the State and National Levels, 2010Students in Grades 9-12

Source: CDC, Youth Online, High School YRBSS, http://apps.nccd.cdc.gov/youthonline/App/Default.aspx

February 2, 2012

Trends in Current Marijuana Use, Massachusetts (1993-2009)Students in Grades 9-12

Source: CDC, Youth Online, High School YRBSS, http://apps.nccd.cdc.gov/youthonline/App/Default.aspx

43%

2010

February 2, 2012

Section 3.State Policy Efforts to Legalize Marijuana in Massachusetts

February 2, 2012

Decriminalization of Marijuana in Massachusetts in 2008

February 2, 2012

Effects of Decriminalization of Marijuana in Massachusetts

• Has changed the way some view marijuana (decreased perception of harm from use of marijuana)

• Increased acceptance for marijuana use• Has made marijuana more accessible to youth • Has created enforcement of marijuana laws

more difficult for law officers• Consequences offer little to no leverage for

getting youth treatment and/or supportFebruary 2, 2012

Current Proposals

• Four main legislative bills for legalization of marijuana– One bill on full legalization (HB 1371)– Two identical bills on medical marijuana (SB 1161

and HB 625)– One other bill on medical marijuana (more

controlled, no distribution)

• Likely statewide ballot initiative (Nov 2012)

February 2, 2012

February 2, 2012

S. Bill 1161 and H. Bill 625

• Allow Mass DPH-certified individuals and caregivers to cultivate marijuana for medical purposes

• Medical conditions include: cancer, glaucoma, HIV/AIDS, Hep C, ALS, Crohn's disease, PTSD, or a chronic or debilitating disease or medical condition, such as chronic pain, seizures, nausea

February 2, 2012

S. Bill 1161 and H. Bill 625

• Allow Mass DPH-designated medical treatment centers/ dispensaries to acquire, possess, cultivate, manufacture, and dispense marijuana and supplies to registered patients and caregivers

February 2, 2012

Statewide Ballot Initiative

• Patients diagnosed by a doctor certifying that they have a debilitating medical condition such as glaucoma, cancer or "other condition" and that the use of marijuana to treat the condition would outweigh the risks

• Patients cleared to buy up to a 60-day supply of marijuana for their personal use from a Mass DPH-certified nonprofit center that would grow the plants

February 2, 2012

Statewide Ballot Initiative

• Legalization of medical marijuana is a step towards legalization of marijuana by marijuana proponents, a well-organized movement

• Very organized and well-funded initiative spearheaded by Massachusetts Patient Advocacy Alliance and MassCANN (members of NORML)

February 2, 2012

H. Bill 1371

• Creates the Cannabis Control Authority to oversee the issuance of licenses for cultivation, processing, trading, retail sales, import, research and farmer-processor-retailer licenses

• Modeled after Chapter 138 of the Massachusetts General Laws, the Alcohol Beverage Control Act

February 2, 2012

H. Bill 1371

• Establishes license fees of varying amounts and excises taxes on cannabis sold at retail

• Allows those 21+ to cultivate cannabis for their personal use and to give cannabis to others 21+

February 2, 2012

Section 4.Business of Marijuana Cultivation, Possession, Use, and Distribution

February 2, 2012

Compassionate care or big business?

$20kAverage $$/day profits per dispensary

February 2, 2012

More dispensaries than Starbucks

Reported in The Daily July 5, 2011Image from thcfinder.com February 2, 2012

Compassionate care increased access to marijuana?

< 5%Only 10% of card holders are cancer, HIV/AIDS, or glaucoma patients

90% are registered for ailments such as headaches and athlete’s foot

February 2, 2012

Compassionate care or increased access to marijuana?

>80%Most card holders in CA and CO are white men between the ages of 17 and 35

No history of chronic illness

History of Alcohol and DrugsSources: O'Connell, T and Bou-Matar , C.B. (2007). Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal, http://www.harmreductionjournal.com/content/4/1/16.

Nunberg, Helen; Kilmer, Beau; Pacula, Rosalie Liccardo; and Burgdorf, James R. (2011) “An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California,” Journal of Drug Policy Analysis: Vol. 4: Iss. 1, Article 1. Available at: http://www.bepress.com/jdpa/vol4/iss1/art1.

Colorado Department of Public Health and Environment, “Medical Marijuana Registry Program Update”, (July 31, 2011).February 2, 2012

What could it mean to have a medical marijuana dispensary or

“treatment center” in Massachusetts?

February 2, 2012

What is the harm? What does all this mean?

• Each card holder is entitled to possess 4-8 ounces of marijuana and up to 24-48 plants depending on the bill

• 1 ounce of marijuana = 60-120 joints

February 2, 2012

What is the harm? What does all this mean?

Allows Massachusetts Department of Public Health (DPH) certified patients to possess and/or cultivate marijuana for “medical” purposes. Allows 4 ounces and 24 plants.

According to NORML, “an ounce of 'standard pot' equals 60 joints...” 1 plant is about 1-5 lbs; 1000 joints/pound240 joints or 24K-120K (potential) joints – per person!

February 2, 2012

Is Marijuana Medicine?

• Whole plant is not medicine• Some constituents, and their synthetics, are:

– Never smoked– Dronabinol (Marinol ®) is synthetic THC delivered

by pill (Schedule III)– Nabilone (Cesamet ®) mimics synthetic THC, also

delivered by pill (Schedule II)

• Other medications in development currently– Today, over 100 DEA-licensed researchers to

research marijuana and its constituentsFebruary 2, 2012

Bypassing the FDA Process

Before FDA approves a drug as medicine, testing is done to:

Determine the benefits and risks of the drug Determine how it may interact with other

drugs Assure standardization of the drug Determine the appropriate dosage levels Identify and monitor side effects Identify the safe means of administering the

drugFebruary 2, 2012

“Medical” Marijuana

The IOM Report (ONDCP commissioned in 1999)• Constituents of the marijuana plant show

promise for treating pain, nausea, wasting

• It is justified to conduct research into marijuana’s active ingredients for conditions or diseases such as pain and nausea, as well as on non-smoked delivery systems

• “..(t)here is little future in smoked marijuana as a medically approved medication.”

February 2, 2012

Cannabinoid-based FDA Approved Drugs

• Sativex is in the process of being studied • Approved in Canada and throughout Europe • Administered via an oral spray

Research on the efficacy of cannabinioids is not focused on raw/crude marijuana, but in the individual components that may have medical use

February 2, 2012

Section 5.Consequences of Legalizing

Marijuana

February 2, 2012

Consequences of Legalizing Marijuana

• 8 out of 10 states with the highest percentage of those aged 12-25 who used Marijuana in the past 30 days were in states that allowed the cultivation and the sale of marijuana for “medicinal” purposes.

• Such states are also the majority of states in the top ten for first time marijuana use rates.

• Decreases of perception of harm.

February 2, 2012

Changes in Attitude Lead to Changes in Use

Marijuana Use and Perceived Risk among 12th Graders, 1975 to 2009

Source: The Monitoring the Future study, the University of MichiganFebruary 2, 2012

Consequences of Legalizing Marijuana

•The younger youth begin to use marijuana, the more likely they are to be addicted to marijuana or other substances later in life.

•Increased crime in states with “medicinal” marijuana laws, especially in states with dispensaries.

• Increases in drugged driving rates.

February 2, 2012

Section 6.Action Steps

February 2, 2012

Action Steps Needed1: Fund efforts to address this threat

2: Follow Legislation and Other Efforts to Change Environment on Marijuana Use

3: Consolidate and Educate Fellow Prevention Community On Marijuana Issues

4: Proactively Support Ideas That Will Gain Widespread Support

5: Create Infrastructure to Educate in the Future on Similar Issues

February 2, 2012

1. Fund The Effort

• Peter Lewis, Founder of Progressive Insurance–$525,000 (over 95%)–Money going to:

• Polling• Signature Collection• Public Relations and

Communications Strategies

February 2, 2012

1. Fund The Effort

• We need funds for:– Expert consultant/coordinator between now and

November (min. $30,000, max. $50,000)• Guidance through all action steps.• Onsite training (through summits and conferences).• Education materials regarding the impact of marijuana

on adolescent development and access, document preparation and creation of outreach documents. (Op-eds, LTEs, etc).

• On-call for emergency documents related to marijuana that require rapid turnaround.

February 2, 2012

1. Fund The Effort

• We need funds for:– Event planning (approx. $13,000)– Materials/messaging/web site/communication costs

(approx. $10,000)– Filing 501c3 & 501c4 (approx. $4,000)

February 2, 2012

2. Follow Efforts

• Extremely well organized and well funded legalization advocates in our state– Massachusetts Patient Advocacy Alliance– Massachusetts Cannabis Reform Coalition: The

Massachusetts chapter of NORML

February 2, 2012

2. Follow Efforts

• Four Main Legislative Bills– Two identical bills on medical marijuana– A more modest bill on medical marijuana– One on full legalization

• Statewide Ballot Initiative?

February 2, 2012

3. Consolidate and Educate Fellow Prevention Community On Marijuana

• Organize Summit

• Organize our allies in one place before major threats progress

• Train them up on media/PR issues, lobbying issues, talking points

• Provide support and structure, form committees and give homework to local folks so they can get our message out

February 2, 2012

What Would a Summit NOT Do?

• Go exhaustively over research findings

• Convince people that marijuana is not a good thing

• Be open to the press

February 2, 2012

Possible Summit Agenda

Why We Are Here

What We Have Learned – Both in MA and other states

Panel Discussion on Issues in Different Area of the State

Talking Points

Grasstops Organizing

Lobbying Rules

Town Hall DiscussionFebruary 2, 2012

Activities at the Summit

• Regional and Sector Workgroups with Specific work plans

• Form Committees for Action

February 2, 2012

Sector Workgroups will:

• List key partners (current or future) in your sector (be specific about group names)

• List key opponents in your sector

• List some strengths and weaknesses of our engagement with this sector (e.g. we have community roots with these groups or we don’t have many contacts in this sector, etc.)

Activities at the Summit

February 2, 2012

Activities at the Summit

• List specific ways we can seek out new allies in our sector

• What will your core messages be to these groups?

• How will you overcome challenges in the messaging to your sector (e.g. if your sector thinks that marijuana is harmless, how will this be overcome?)

February 2, 2012

Activities at the Summit

• How will you engage the media on this issue from your sector’s perspective? (Be as specific as possible – e.g. name specific news outlets in your areas and how you will target)

• List Milestones Your Group will Achieve

February 2, 2012

Committees

TopicGoalCommittee Tasks

Committee Membership- Chair- Members

February 2, 2012

Objectives/Milestones

Deliverable - description

Champions

Due Date

Check Box

February 2, 2012

Conference (closer to date of major legislation/action)

• Once key dates are identified (general referenda vote, etc.)

• Invite public officials and the media

• Major press conference with key leaders

February 2, 2012

5. Proactively Support Ideas That Will Gain Widespread Support

• Sensible policies that legislators and others can rally around

– E.g. The idea of speeding up research into nonsmoked marijuana components and encouraging research protocols as recommended by the 1999 IOM report on marijuana as medicine

February 2, 2012

4. Create Infrastructure to Educate in the Future on Similar Issues

• The model we create can work for future campaigns, on marijuana and other issues that may arise.

February 2, 2012

Where Do We Go From Here?

• Obtain resources to support the efforts and the organizational structure

• Prepare for mid-April Summit

• Meet lawmakers and tell them what we are about, and get known among lawmakers

• Keep track of legislative and other developments

February 2, 2012

Immediate Step #1

• Sign up to be a member of a committee!

– Organization Development Committee: Set up 501c3 w/ leadership.

– Summit Committee: Plan event with all details.– Resource Development Committee: Secure funding for

this state-wide initiative. Identify potential funders, make contact and generate funding support.

– Outreach and membership Committee: Build participation at Summit and in MAPA.

– Communications Committee: Internal and external resource portal. Tools and website.

February 2, 2012

Immediate Step #2

• Help us fund the initiative!

– Contribute coalition grant funds– Donate personally– Join our fundraising efforts

February 2, 2012

Organizational Development Committee

• Chair: Tami Gouveia• Membership: 3-4 people• Time commitment: 2-4 hours per month• Develop a 1 and 2 year strategic action plan to

develop the organization • Support the Steering Committee in determining

incorporation options• Develop materials and tools to support the

development of MAPA• Reports to the Steering Committee

February 2, 2012

Organizational Development Timeline

Feb. 2012 May 2012

Phase 4:Implement Plan

Monitor Progress

Phase 1: Agree on Vision & Mission

Apr. 2012

Phase 3:File 501 © 3

Develop Action Plan with

Benchmarks

Mar. 2012

Phase 2:Develop

Business Plan & Documents for Incorporation

Planning MAPA Building MAPA

February 2, 2012

Summit Planning Committee

• Chair: Kirsten Doherty• Membership: 4-5 people• Timeframe: Now – April 2012• Time commitment: 6-8 hours per month• Reports to the Steering Committee

February 2, 2012

Summit Planning Committee

Goal: Implement a state-wide Summit for 150-200 people

to build a base of members, donors and advocates to support the MA Prevention Alliance and its advocacy efforts.

How:– Planning day– Marketing– Logistics

February 2, 2012

Resource Development Committee

• Leadership: volunteer Co-chairs• Membership: 7-10 people representing MA

regions (boundaries to be defined)• Timeframe: Now – December 2012• Time commitment: 6-8 hours per month• Reports to Steering Committee

February 2, 2012

Resource Development Committee

Goal:

Raise money and in-kind donations by December 2012 from individuals and entities across Massachusetts to support MAPA and advocacy efforts.

How:– Research and identify potential funders– Solicit gifts from individuals, businesses,

foundations, etc.– Create infrastructure for raising and tracking funds

February 2, 2012

Outreach & Membership Committee• Chair: Dave Shavel• Membership: 5-7 people• Identify specific individual and organizations to

engage• Determine the most appropriate way to engage

and educate• Work with other committees to develop

outreach and education materials• Develop recruiting and member orientation

materials and coordinate recruiting efforts• Follow up and orient new members• Reports to Steering Committee

February 2, 2012

Outreach and Membership TimelineJan. 2012 Apr. 2012 Aug. 2012 Nov. 2012

Kick-off Summit Election

Phase 2:Build

Partnerships

Phase 1: Recruit

Allies

Phase 3:Public

Advocacy

Phase 4:Celebrate &

Follow Up

Recruit Allies: Identify key individuals and organizations who support the campaign. Clarify potential roles and invite to the Summit in April.

Build Partnerships: Expand outreach to individuals and organizations that can organize and recruit local and statewide supporters and advocates. Provide information and training to the individuals and organizations.

Public Advocacy: Public awareness campaign to educate the public and “get out the vote” campaign.

Celebrate and Follow Up: Celebrate the victory and follow Up as needed.

Campaign Kick-off

February 2, 2012

Communications Committee

• Chair: Carol Read• Membership: 3-4 people• Develop website layout and content• Compile and distribute educational resources• Develop talking points and MAPA materials• Track media outlets and networks• Develop system for regular communications

with partners• Reports to Steering Committee

February 2, 2012

Committee Chairs

• Organizational Development Committee– Tami Gouveia, tamigouveia@mapreventionalliance.org

• Summit Planning Committee– Kirsten Doherty, kirstendoherty@mapreventionalliance.org

• Resource Development Committee– info@mapreventionalliance.org

• Outreach and Membership Committee– Dave Shavel, daveshavel@mapreventionalliance.org

• Communications Committee– Carol Read, carolread@mapreventionalliance.org

February 2, 2012